47
Participants
Start Date
April 30, 2013
Primary Completion Date
October 31, 2015
Study Completion Date
December 31, 2015
Ranolazine
Subject will receive labeled bottles containing tablets with ranolazine 500 mg or a matching placebo provided by the sponsor. Each patient will receive both ranolazine and placebo for 4 weeks, but both the investigator and subject are blinded to the order.
Placebo
Subject will receive labeled bottles containing tablets with ranolazine 500 mg or a matching placebo provided by the sponsor. Each patient will receive both ranolazine and placebo for 4 weeks, but both the investigator and subject are blinded to the order.
Brigham and Women's Hospital, Boston
Brigham and Women's Hospital
OTHER